Arama

EISSN 2979-9139

FORMERLY: TURKISH THORACIC JOURNAL SCOPUS CITESCORE: 1.4 OPEN ACCESS NO APCs INDEXED IN: PUBMED CENTRAL INDEXED IN: WEB OF SCIENCE AND SCOPUS

Thoracic Research and Practice

PDF

MOST READ ARTICLES

Examining Visfatin As a New Sarcoidosis Biomarker

Tanrıverdi et al.

Patients with Large-Cell Neuroendocrine Carcinoma

Çırak et al.

Asthma, Preoperative Risk Assessment

Erdoğan et al.

HIGHLY CITED ARTICLES

Chronic Pulmonary Diseases and COVID-19

By: Edis, EC

Turkish Thoracic Society Experts Consensus Report: Recommendations for Pulmonary Function Tests During and After COVID 19 Pandemic

By: Gemicioglu, B; Borekci, S; Dilektasli, AG; et al.

Health Hazards and Complications Associated with Electronic Cigarettes: A Review

By: Gulsen, A and Uslu, B

Validity and Reliability of the Turkish Version of the London Chest Activity of Daily Living Scale in Obstructive Lung Diseases

By: Saka, S; Savci, S; Kutukcu, EC; et al.

Which Screening Questionnaire is Best for Predicting Obstructive Sleep Apnea in the Sleep Clinic Population Considering Age, Gender, and Comorbidities?

By: Arslan, BO; Hosgor, ZZU and Orman, MN

Prevalence of Zinc Deficiency and the Effect of Zinc Supplementation on the Prevention of Acute Respiratory Infections

By: Khera, D; Singh, S; Purohit, P; et al.

Pulmonary Embolism in Covid-19: Coagulation Parameters, Close Monitoring to Prevent?

By: Annunziata, A; Imitazione, P; Polistina, GE; et al.

Self-Management Training in Chronic Obstructive Lung Disease Improves the Quality of Life

By: Ozturk, BO; Alpaydin, AO; Ozalevli, S; et al.

Evidence Based Treatment of SARS-CoV2: A Narrative Review

By: Agrawal, S; Gupta, N and Goel, AD

What We Learned about COVID-19 So Far? Notes from Underground

By: Akyil, FT; Karadogan, D; Gurkan, CG; et al.

All Title Keyword Full Text DOI

Authors

Article Type

Article Category

Year

Search Results

Total of 6 results

Ranking

Release Date Sort Sort Article Type

Analysis of Prognostic Factors in Stage IIIB-IV Non-Small Cell Lung Cancer Cases who Received Chemotheraphy

Sibel Arınç, Nuray Erdal, Ferah Ece, Nilgün Hatabay, Özlem Oruç, Armağan Hazar

(Thorac Res Pract 2010; 11: 93-97) DOI: 10.5152/ttd.2010.11

Abstract Full Text ( PDF) Related Articles

Can Serum Lactate Dehydrogenase Level be Used for Predicted to IPF Clinical Severity?

Elif Yelda Niksarlıoğlu, Güngör Çamsarı, Mehmet Atilla Uysal, Emel Taş, Ayşe Yeter, Gülşah Günlüoğlu

(Thorac Res Pract 2019; 20: 158-158) DOI: 10.5152/TurkThoracJ.2019.158

Abstract Full Text ( PDF) Related Articles

Characteristics of Patients with Large-Cell Neuroendocrine Carcinoma of the Lung

Ali Kadri Çırak, Kenan Can Ceylan, Yelda Varol, Gülistan Karadeniz, Zekiye Aydoğdu, Arkın Acar, Günseli Balcı, Berna Kömürcüoğlu, Aydan Mertoğlu, Zeynep Öndeş, Serpil Tekgül, Görkem Vayısoğlu, Enver Yalnız

(Thorac Res Pract 2020; 21: 150-155) DOI: 10.5152/TurkThoracJ.2019.180166

Abstract Full Text ( PDF) Related Articles

Analysis of Prognostic Factors in Stage IIIB-IV Non-Small Cell Lung Cancer Cases who Received Chemotheraphy

Can Serum Lactate Dehydrogenase Level be Used for Predicted to IPF Clinical Severity?

Characteristics of Patients with Large-Cell Neuroendocrine Carcinoma of the Lung

The Role of Sublobar Resection in T1 N0 Non-Small-Cell Pulmonary Carcinoma

Synchronous Lung Tumors

Determination of the Best Treatment Option in Stage III, Resectable, Non-small Cell Lung Cancer Patients by Decision Analysis Method